Cloning, sequencing and functional expression of zebra (Equus burchelli) LH.
(57/6154)
Although donkey luteinizing hormone exhibits a very high degree of amino acid sequence identity with horse LH, its FSH activity in non-equine species is tenfold lower. The coding regions of the common zebra (Equus burchelli) glycoprotein hormone alpha-subunit and LH beta-subunit transcripts were cloned by reverse transcription-PCR from pituitary gland RNA to investigate more precisely the structure-function relationships of this gonadotrophin family. Zebra LH was then expressed in COS-7 cells and its LH and FSH activities were assessed in a rat Leydig cell bioassay (for LH) and in a cell line stably expressing the human FSH receptor bioassay (for FSH). The recombinant zebra LH, although displaying LH activity similar to that of recombinant donkey and horse LH, had no detectable FSH activity. The LH amino acid sequences of these three species are very similar, leaving only very few amino acids as potential candidates to explain the difference in their FSH activities. Moreover, according to the difference in FSH bioactivity and to the percentage identity between the sequences, the common zebra is phylogenetically closer to the donkey than it is to the horse. (+info)
Influence of cumulative feed intake during early and mid-lactation on luteinizing hormone secretion and weaning-to-estrus interval in primiparous sows.
(58/6154)
Twelve pregnant gilts were assigned to a completely randomized block design with two treatments in two blocks (2 farrowing groups). The treatments were a feeding amount of 6 kg or 2 kg/day provided during lactation. The lactation diet contained 18.6% crude protein, 1.0% lysine, and 3.27 Mcal/kg metabolizable energy (as-fed basis). Litters were weaned at 2100 on day 21 after farrowing. Blood samples for luteinizing hormone (LH) measurements were taken at 15-min intervals for 8 hr on day 12 of lactation, and samples for glucose and insulin were collected at 1-hr intervals for 3 hr on day 12. The effects of feed intake treatments on LH pulse frequencies (2.9 vs 0.7) and insulin concentrations (15.0 vs 8.9 IU/mL) were found (P < 0.05) on day 12 of lactation. In regression analysis, greater cumulative feed intake from 1 to 12 days was associated with higher insulin concentrations (P = 0.04), greater LH pulse frequencies (P = 0.01) on day 12 of lactation, and shorter weaning-to-estrus intervals (WEI) (P = 0.03). Furthermore, an association between insulin concentrations and LH pulse frequencies was found on day 12 of lactation (P = 0.01). Using regression models for weaning-to-estrus interval, when each cumulative feed intake from 4 to 21 days was used as an independent variable, the R2 values increased from 0.24 to 0.37. These results suggest that feed intake during early and mid-lactation influences LH secretion as early as day 12 after farrowing, and is associated with shorter WEI. This research also indicates that feed intake from 4 to 12 days of lactation is more important than that during the first few days after farrowing. (+info)
Inhibitory effect of melatonin on GnRH-induced LH release.
(59/6154)
Melatonin inhibits GnRH-induced release of LH and FSH from the neonatal, but not the adult, rat anterior pituitary gland. This action of melatonin is mediated by the specific high-affinity membrane-bound receptors that are absent in adult rats. The intracellular mechanism of melatonin action involves a decrease in intracellular calcium [Ca2+]i in the gonadotrophs; melatonin inhibits GnRH-induced Ca2+ release from endoplasmic reticulum as well as Ca2+ influx through voltage-sensitive channels. Melatonin also inhibits GnRH-induced accumulation of cAMP, which may result in the decreased influx of Ca2+, because cAMP, acting through protein kinase A, stimulates Ca2+ influx into the gonadotrophs. This age-dependent effect of melatonin on gonadotrophin release from the pituitary may be involved in the timing of puberty. (+info)
Transcriptional regulation of pituitary gonadotrophin subunit genes.
(60/6154)
The gonadotrophic hormones, LH and FSH, are synthesized in and secreted from gonadotroph cells in the anterior pituitary and comprise a common alpha-subunit and a hormone-specific beta-subunit. Gonadotrophic gene expression is activated during embryogenesis, independent of GnRH stimulation and increases as GnRH output increases, reaching adult levels at puberty. The transcriptional regulation of pituitary gonadotrophin subunit gene expression is regulated by two types of transcription factor: those that restrict and direct gene expression to gonadotrophs and those that modulate GnRH-regulated gene expression. Synergism between these two types of factor ensures gonadotroph-specific GnRH-regulated gene expression. It is not known whether these two types of transcription factor are mutually exclusive or whether they have overlapping functions. GnRH-regulated gonadotrophin subunit gene expression is modulated by transcription factors controlled by a complex interaction of GnRH, steroids and gonadal peptides, all of which bind to receptors that activate disparate intracellular signalling pathways. It remains to be established how these signalling pathways interact to transduce specific transcriptional activation of common alpha-subunit and LH and FSH beta-subunit gene expression. (+info)
Luteal phase and clinical outcome after human menopausal gonadotrophin/gonadotrophin releasing hormone antagonist treatment for ovarian stimulation in in-vitro fertilization/intracytoplasmic sperm injection cycles.
(61/6154)
The luteal phase hormonal profile and the clinical outcome of 69 patients undergoing in-vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) after ovarian stimulation with human menopausal gonadotrophin (HMG) and the gonadotrophin-releasing hormone (GnRH) antagonist Cetrorelix were analysed. Twenty-four patients received Cetrorelix 0.5 mg (group I) while in 45 patients Cetrorelix 0.25 mg was administered (group II). Human chorionic gonadotrophin (HCG) was used as luteal support. Nine clinical pregnancies were obtained in group I (37.5%) and 12 in group II (26. 6%). These results were not significantly different. Serum progesterone and oestradiol concentrations did not differ between the two groups either in pregnant or non-pregnant patients. An expected decrease of the same hormones was observed 8 days after the pre-ovulatory HCG injection in non-pregnant women. With regard to serum luteinizing hormone concentrations, a decrease was observed 2 days after the pre-ovulatory HCG injection and was maintained at almost undetectable levels throughout the entire luteal phase in both conception and non-conception cycles of group I and group II. This study demonstrates that different doses of GnRH antagonist do not have any impact on the luteal phase of IVF/ICSI cycles when hormonal support is given. (+info)
Are circulating leptin and luteinizing hormone synchronized in patients with polycystic ovary syndrome?
(62/6154)
Animal and human studies suggest that leptin modulates hypothalamic-pituitary-gonadal axis functions. Leptin may stimulate gonadotrophin-releasing hormone (GnRH) release from the hypothalamus and luteinizing hormone (LH) and follicle stimulating hormone (FSH) secretion from the pituitary. A synchronicity of LH and leptin pulses has been described in healthy women, suggesting that leptin probably also regulates the episodic secretion of LH. In some pathological conditions, such as polycystic ovarian syndrome (PCOS), LH-leptin interactions are not known. The aim of the present investigation was to assess the episodic fluctuations of circulating LH and leptin in PCOS patients compared to regularly menstruating women. Six PCOS patients and six normal cycling (NC) women of similar age and body mass index (BMI) were studied. To assess episodic hormone secretion, blood samples were collected at 10-min intervals for 6 h. LH and leptin concentrations were measured in all samples. For pulse analysis the cluster algorithm was used. To detect an interaction between LH and leptin pulses, an analysis of copulsatility was employed. LH concentrations were significantly higher in the PCOS group in comparison to NC women, however serum leptin concentrations and leptin pulse characteristics for PCOS patients did not differ from NC women. A strong synchronicity between LH and leptin pulses was observed in NC women; 11 coincident leptin pulses were counted with a phase shift of 0 min (P = 0.027), 18 pulses with a phase shift of -1 (P = 0.025) and 24 pulses with a phase shift of -2 (P = 0.028). PCOS patients also exhibited a synchronicity between LH and leptin pulses but weaker (only 20 of 39 pulses) and with a phase shift greater than in normal women, leptin pulses preceding LH pulses by 20 min (P = 0.0163). These results demonstrate that circulating leptin and LH are synchronized in normal women and patients with PCOS. The real significance of the apparent copulsatility between LH and leptin must be elucidated, as well as the mechanisms that account for the ultradian leptin release. (+info)
Purification of a candidate gonadotrophin surge attenuating factor from human follicular fluid.
(63/6154)
Gonadotrophin surge attenuating factor (GnSAF) is a new non-steroidal ovarian substance, different from inhibin, which attenuates the pre-ovulatory luteinizing hormone (LH) surge in superovulated women. Human follicular fluid (FF) was used as a source for the isolation of GnSAF, the activity of which was monitored in an in-vitro pituitary bioassay. Primary rat pituitary cells were incubated with test substances for 48 h and subsequently washed and incubated with 0.1 micromol/l gonadotrophin releasing hormone (GnRH) plus test substances for 4 h. GnSAF activity was expressed as the reduction of GnRH-induced LH secretion in the 4 h incubation. GnSAF was purified from 250 ml of FF which was heat-treated at 80 degrees C for 5 min. Heparin-sepharose chromatography, Con-A sepharose chromatography, reversed-phase high-performance liquid chromatography (HPLC) and preparative native gel electrophoresis were used for GnSAF fractionation. Using these purification steps, we have obtained an apparently homogeneous preparation that stains as a single band on sodium dodecyl sulphate (SDS)-polyacrylamide gel electrophoresis. GnSAF has an apparent molecular weight of 12.5 kDa and was identified by amino acid sequence (mass spectrometry) to be the C-terminal fragment of human serum albumin. (+info)
Is glycosylated haemoglobin a marker of fertility? A follow-up study of first-pregnancy planners.
(64/6154)
We performed a follow-up study of time to pregnancy in a population of first-time pregnancy planners without previous reproductive experience. The objective of this paper is to report and discuss a finding of a strong relationship between glycosylated haemoglobin (HbA1C) and fertility. A total of 165 Danish couples without previous reproductive experience was followed from termination of birth control until pregnancy for a maximum of six menstrual cycles. HbA1C and reproductive hormones were measured at entry. Questionnaire data were collected at entry and once in each cycle during follow-up. The odds ratio (OR) for pregnancy per cycle decreased with increasing concentration of HbA1C (OR per percent HbA1C 0.4, 95% CI 0.2-0.9 for all six cycles and 0.2, 95% CI 0.1-0.5 in the first three cycles). A high concentration of HbA1C was associated with a high concentration of testosterone and a low concentration of inhibin A. No association was found between HbA1C and psychosocial distress. The reduced fertility among women with high HbA1C may be due to an association with subclinical polycystic ovaries as indicated by the hormonal profile. (+info)